In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Roche licenses in vitro diagnostics employing PacBio’s SMRT technology; terminated

Executive Summary

Pacific Biosciences of California Inc. (high-resolution genetic analysis) licensed Roche’s Roche Diagnostics Corp. exclusive global rights to sell in vitro diagnostics--including sequencing systems and consumables--that incorporate PacBio’s Single Molecule, Real-Time (SMRT) platform. Roche’s license covers human clinical use, limited to medical management of a human being and quality control or testing of human blood or tissue for transfusion or blood banking, human bone marrow transplantation or banking, or human tissue typing for transplantation. PacBio retains rights in all other fields including research, plant, animal, and applied markets.
Deal Industry
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Terminated
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies